WADA 2026 Annual Report: Testing Growth Decelerates and Two Unpaid Debts

An athlete steps onto the starting blocks for the 200m individual medley final. The stands watch her. I watch behind the stands — where a sample collection officer is checking the seal on a kit box. People watch the goal; I watch the ten passes before it. In swimming, those "ten passes" usually sit outside the pool: a chain of out-of-competition tests, an athlete biological passport, a monitoring system the audience never sees but which decides who is permitted to stand on the podium.

When the World Anti-Doping Agency (WADA) released its annual report labelled 2026, I read it that way.

The report compiles operational data for the global anti-doping system across 2026. Three main data axes: sample testing volume, the adverse analytical finding (AAF) rate, and the organisation's finances. WADA also confirmed the 2027 World Anti-Doping Code was adopted in Busan, South Korea, taking effect on January 1, 2027.

Testing volume reached 288,865 samples in 2026 and 297,965 in 2026 — roughly 9,100 additional samples, a 3.2% increase. Looking back, growth from 2026 to 2026 was 12.5%. The growth rate fell nearly fourfold in a single year.

The AAF rate was essentially flat: 0.77% in 2026, 0.80% in 2026, 0.78% in 2026. The three-year band is just 0.03 percentage points. The data series runs continuously from 2026 to 2026, long enough for this baseline to carry statistical meaning.

Together, these three facts tell a different story from the headline "WADA increases sample testing."

Growth is decelerating clearly, from 12.5% to 3.2%. If this curve flattens further, the system hits a ceiling — and the cause is less likely to be lack of demand than lack of resources.

I have seen a similar pattern in swimming data. An athlete improves very quickly early in a training cycle, then plateaus. That plateau is usually not a sign of laziness but of a physical limit arriving. For WADA, that physical limit has a name: budget.

An AAF rate holding near 0.78% for three years is the most analytically valuable finding in the whole report. It is stable enough to be a genuine baseline rather than noise. When sample volume rises while the detection rate holds still, there are two explanations: the underlying prevalence of doping is unchanged, or the system is testing more broadly but reaching a population with comparable positivity. The dataset cannot separate these two.

Then comes the part that made me pause longest. Among non-conformity findings against the Code, 45% relate directly to the testing process — up 11% year on year, with 23% of those classified as critical. Average non-conformities among audited organisations fell, from 25.5 to 20. But the audit sample was only nine reviews. Nine. That is too thin a base to claim the system is healthier. And the rise in testing-related findings is a counter-signal — a weakness hidden behind an improving average.

On finances: WADA recorded a shortfall of $8.3 million against budget. The United States has not paid $3.8 million. Russia owes $3.9 million. The organisation still reports a net surplus of $1.2 million. A net surplus coexisting with a large shortfall usually means cost-cutting or deferred spending. For an organisation whose core activity is testing, deferred spending almost always means reduced investment in testing itself.

One detail about the time label deserves note. The report carries a 2026 label but compiles testing figures from 2026 and 2026, while the financial section attaches to income year 2026. This is most likely a one-year publication-lag convention — a 2026 report reflecting 2026 activity. Anyone citing it should verify this before using the figures, because mixing up year labels is a common error in sports analysis.

The counter-intuitive angle sits here: the biggest problem in the anti-doping system is probably not how many athletes are doping, but who is paying to detect them.

The report notes a strategic shift: WADA is moving from traditional testing toward investigations and prevention. More than 250 investigation operations, 88 laboratories dismantled, over 90 tonnes of materials seized. These are impressive results. They also expose a different logic: targeted investigation delivers more impact per dollar than blanket testing. When budgets tighten, the organisation leans toward the more efficient option.

For swimming, the consequences are structural. Swimming is a heavy sample consumer — many events, many rounds, many athletes at grassroots level. If resources shift toward targeted investigation, testing coverage at smaller federations thins first. Nobody announces this. It happens quietly, through budget allocation.

The report also notes a legitimacy highlight: WADA, with the Athlete Council, ran consultations with over 600 athletes and committees across more than 60 countries and 70 sports. Yet the report offers no measure showing athlete input actually changed the Code's substance. Legitimacy is being built; real enforcement remains unverified.

At 50, I admit openly: it took me three years to understand the data tornado is not something to fear but to ride. But data can only be ridden when it is thick enough. With nine compliance reviews and a flattening curve, this is a moment to read the numbers with caution, not optimism.

January 1, 2027 is a real milestone with a specific date. From now until then is a transition window — a period when national organisations still operate under old rules while the new ones are already signed. Those who prepare early carry less risk.

Football without spectators is a missing piece in humanity's dataset. An underfunded anti-doping system is a missing piece in another way — and harder to notice, because it leaves no empty seats in the stands. It leaves only a question no scoreboard can answer: if the lane has no tester, who will be the first to notice?